Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Tissue Thickness Effects on Immunohistochemical Staining Intensity of Markers of Cancer.

McCampbell AS, Raghunathan V, Tom-Moy M, Workman RK, Haven R, Ben-Dor A, Rasmussen OF, Jacobsen L, Lindberg M, Yamada NA, Schembri C.

Appl Immunohistochem Mol Morphol. 2017 Oct 27. doi: 10.1097/PAI.0000000000000593. [Epub ahead of print]

PMID:
29084061
2.

Loss of p27 Associated with Risk for Endometrial Carcinoma Arising in the Setting of Obesity.

McCampbell AS, Mittelstadt ML, Dere R, Kim S, Zhou L, Djordjevic B, Soliman PT, Zhang Q, Wei C, Hursting SD, Lu KH, Broaddus RR, Walker CL.

Curr Mol Med. 2016;16(3):252-65.

3.

Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer.

Kim TH, Lee DK, Cho SN, Orvis GD, Behringer RR, Lydon JP, Ku BJ, McCampbell AS, Broaddus RR, Jeong JW.

Cancer Res. 2013 Aug 15;73(16):5090-9. doi: 10.1158/0008-5472.CAN-13-0241. Epub 2013 Jun 27.

4.

Chemopreventive effects of metformin on obesity-associated endometrial proliferation.

Zhang Q, Celestino J, Schmandt R, McCampbell AS, Urbauer DL, Meyer LA, Burzawa JK, Huang M, Yates MS, Iglesias D, Broaddus RR, Lu KH.

Am J Obstet Gynecol. 2013 Jul;209(1):24.e1-24.e12. doi: 10.1016/j.ajog.2013.03.008. Epub 2013 Mar 15.

5.

Sex hormone regulation of survivin gene expression.

Nabilsi NH, Broaddus RR, McCampbell AS, Lu KH, Lynch HT, Chen LM, Loose DS.

J Endocrinol. 2010 Nov;207(2):237-43. doi: 10.1677/JOE-10-0128. Epub 2010 Aug 26.

6.

Loss of inhibitory insulin receptor substrate-1 phosphorylation: An early event in endometrial hyperplasia and progression to carcinoma.

McCampbell AS, Broaddus RR, Walker CL.

Cell Cycle. 2010 Jul 15;9(14):2698-9. Epub 2010 Jul 9. No abstract available.

PMID:
20676044
7.

Loss of inhibitory insulin receptor substrate-1 phosphorylation is an early event in mammalian target of rapamycin-dependent endometrial hyperplasia and carcinoma.

McCampbell AS, Harris HA, Crabtree JS, Winneker RC, Walker CL, Broaddus RR.

Cancer Prev Res (Phila). 2010 Mar;3(3):290-300. doi: 10.1158/1940-6207.CAPR-09-0199. Epub 2010 Feb 23.

8.

Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway.

Crabtree JS, Jelinsky SA, Harris HA, Choe SE, Cotreau MM, Kimberland ML, Wilson E, Saraf KA, Liu W, McCampbell AS, Dave B, Broaddus RR, Brown EL, Kao W, Skotnicki JS, Abou-Gharbia M, Winneker RC, Walker CL.

Cancer Res. 2009 Aug 1;69(15):6171-8. doi: 10.1158/0008-5472.CAN-08-4471. Epub 2009 Jul 21.

9.

Enhanced estrogen-induced proliferation in obese rat endometrium.

Zhang Q, Shen Q, Celestino J, Milam MR, Westin SN, Lacour RA, Meyer LA, Shipley GL, Davies PJ, Deng L, McCampbell AS, Broaddus RR, Lu KH.

Am J Obstet Gynecol. 2009 Feb;200(2):186.e1-8. doi: 10.1016/j.ajog.2008.08.064.

10.

Developmental reprogramming of IGF signaling and susceptibility to endometrial hyperplasia in the rat.

McCampbell AS, Walker CL, Broaddus RR, Cook JD, Davies PJ.

Lab Invest. 2008 Jun;88(6):615-26. doi: 10.1038/labinvest.2008.29. Epub 2008 Apr 21.

11.

Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium.

McCampbell AS, Broaddus RR, Loose DS, Davies PJ.

Clin Cancer Res. 2006 Nov 1;12(21):6373-8.

Supplemental Content

Loading ...
Support Center